As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...

The benefits of taking GLP-1 agonists seem to outweigh the risks, at least when taken for approved uses, according to an ...

The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 ...

A new study highlighted Monday the potential benefits of popular diabetes drugs on a wide range of health issues including ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...

In all, researchers found that people taking GLP-1 medications had lower risks for 42 health outcomes, including liver ...

Some outcomes, like reduced risk of cardiovascular disease and increased chance of nausea, were expected. But others took researchers by surprise.

Over 2 million people were included in new research to test these drugs against 175 different health outcomes.

Read More: Patients Are Suing Over Alleged Side Effects of Weight-Loss Drugs ...

The findings, based on an analysis of records from 2.5 million VA patients, support much of what scientists already suspected ...

The race is on for new drugs that suppress appetite, improve glucose regulation and can replace injections. But do they ...

A study analyzing data from over 2 million veterans found that GLP-1 receptor agonists, popular weight-loss drugs like ...